Neurodegeneration – Multimedia

This infographic outlines the mechanisms at the heart of PD and highlights investigational therapies, from gene and cell-based approaches to innovations targeting α-synuclein and neuroinflammation.

This article introduces the role of kinases in neurodegenerative diseases, the development of kinase inhibitors for the treatment of AD, PD, and ALS, as well as the challenges in developing kinase-targeted drugs

This article reviews pathological and physiological role of Tau proteins in neurodegeneration, Tau-targeted drug development strategies, and SignalChem’s contribution

This listicle uncovers spatial biology's journey, from foundational techniques to cutting-edge technologies that define the present.

This whitepaper explores the translational and clinical applications of IMC to develop biomarkers and future treatment strategies in neuro-oncology and neurodegenerative studies.

This application note demonstrates how imaging mass cytometry (IMC) is transforming neurodegeneration research, providing detailed visualization of protein aggregates, neuron populations and inflammatory cell interactions.

The quest to understand complex diseases has driven significant advancements in proteomics, and researchers continue to make important discoveries by mapping the intricate networks of proteins at work in the body.

In this episode we speak with bit.bio about astrocytes and how bit.bio's innovative technology is transforming research in this area.

Targeted protein degradation (TPD) is getting a lot of attention as a promising modality to treat a variety of diseases from cancer to Alzheimer’s.

This whitepaper explores innovative proteomic tools that offer insights into protein signatures and that can serve as biomarkers for aging.